RSV

Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
Yahoo/PR NewsWire
Sat, 01/30/10 - 11:11 am
MedImmune
motavizumab
RSV
MedImmune responds to FDA on pediatric drug
Bizjournals.com
Mon, 12/28/09 - 04:42 am
FDA
MedImmune
Synagis
RSV
MedImmune licenses RSV antibodies in $338M deal
Fierce Biotech
Tue, 12/1/09 - 10:25 am
RSV
antibodies
MedImmune
liscensing
Trellis Biosciences
Novavax gets grant for respiratory virus vaccine
Yahoo/AP
Tue, 10/13/09 - 10:21 am
vaccines
Novavax
RSV

Pages